In addition, we observed a negative correlation between S-I-specific CD4+ T cells and the CD4+HLADRhiICOS+CD226+ sub-cluster (T1) in aCD20-treated MS patients (Fig. 5H). This evidence concerns the gene CD4 and myeloid sarcoma.